I have consistently been involved in scientific and corporate research and analysis. After receiving my PhD from the University of Tokyo, I joined IMS Consulting Group (now IQVIA), a consulting firm specializing in pharmaceuticals, where I worked primarily with foreign pharmaceutical companies. I then joined Nomura Securities, where I oversaw privately owned biotech or health-tech ventures, including our company. I joined RegCell in August 2022 and was appointed as a director in September 2022. I work as Chief Operating Officer overseeing corporate, finance, business development, and Investor Relations/PR departments.